| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VCNX | Common Stock | Purchase | $577,409 | +100,629 | +18% | $5.74 | 663,044 | 31 Jul 2024 | By FCMI Parent Co. | F3, F4 |
| transaction | VCNX | Common Stock | Purchase | $533,588 | +83,243 | +13% | $6.41 | 746,287 | 31 Jul 2024 | By FCMI Parent Co. | F3, F5 |
| transaction | VCNX | Common Stock | Purchase | $119,283 | +16,128 | +2.2% | $7.40 | 762,415 | 31 Jul 2024 | By FCMI Parent Co. | F3, F6 |
| holding | VCNX | Common Stock | 2,094 | 31 Jul 2024 | Direct | ||||||
| holding | VCNX | Common Stock | 180 | 31 Jul 2024 | By Pan Atlantic Holdings Ltd. | F1 | |||||
| holding | VCNX | Common Stock | 16,724 | 31 Jul 2024 | By Friedberg Global-Macro Hedge Fund Ltd. | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | VCNX | Warrant (Right to Buy) | 102,960 | 31 Jul 2024 | Common Stock | 102,960 | $7.64 | By FCMI Parent Co. | F3 | |||||
| holding | VCNX | Warrant (Right to Buy) | 118,226 | 31 Jul 2024 | Common Stock | 118,226 | $14.00 | By FCMI Parent Co. | F3 | |||||
| holding | VCNX | Warrant (Right to Buy) | 214,285 | 31 Jul 2024 | Common Stock | 214,285 | $14.00 | By FCMI Parent Co. | F3 |
| Id | Content |
|---|---|
| F1 | Mr. Friedberg is the majority owner of Pan Atlantic Holdings Ltd. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |
| F2 | Mr. Friedberg possesses voting and dispositive power over the reported securities and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |
| F3 | Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |
| F4 | The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.10 to $6.10, inclusive. The reporting persons undertake to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F5 | The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.11 to $7.06, inclusive. The reporting persons undertake to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F6 | The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.18 to $7.40, inclusive. The reporting persons undertake to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |